Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
Ticker SymbolVTAK
Company nameCatheter Precision Inc
IPO dateSep 27, 2018
Founded at2018
CEOMr. David A. Jenkins
Number of employees22
Security typeOrdinary Share
Fiscal year-endSep 27
Address1670 Highway 160 West
CityFORT MILL
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code29708
Phone19736912000
Websitehttps://www.ramed.com/
Ticker SymbolVTAK
IPO dateSep 27, 2018
Founded at2018
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data